---
layout: post
title: "First Renishaw neuromate® robot installation in Saudi Arabia"
background: '/img/posts/alanthealth.jpg'
date: 2014-02-01
---

<h2>First Renishaw neuromate® robot installation in Saudi Arabia</h2>

<p><strong>February 2014</strong> - Renishaw is pleased to announce that its stereotactic neurosurgical robotic system, neuromate®, has received marketing authorisation for sale in the Kingdom of Saudi Arabia by the Saudi Food and Drug Authority. A neuromate® system has recently been installed and the first surgical procedures have been performed at the King Fahad Medical City Hospital in Riyadh. This is the first placement of a neurosurgical robot in the Kingdom of Saudi Arabia.</p>

<p>Prof. Mahmoud al Yamany, Chief Executive Officer of King Fahad Medical City, a Neurosurgeon by training, said, "The newly acquired neuromate® system will provide our neurosurgical team with cutting-edge robotic technology that enables the surgeons to deliver neuro-implantable devices with the highest accuracy. We are excited about the new possibilities we have with a neurosurgical robot in our operating room, and are pleased to be the first center in Saudi Arabia to offer robotic neurosurgery to our patients."</p>

<p>Dr Ismail Ahmed, President of Gulf Medical said; "Working with Renishaw to bring in the neuromate® to Saudi Arabia is consistent with Gulf Medical's long history of introducing proven medical innovations into the kingdom."</p>

<p>Dr. Abed Hammoud, CEO of Renishaw Mayfield SA said; "We are proud of this newest installation in Saudi Arabia. Yet another team of leading neurosurgeons has chosen the neuromate® system and Renishaw as a partner in the neurosurgical operating room."</p>

<p>The neuromate® is in use at many leading neurosurgical centers around the world, with France having the largest installed base (with 7 units currently in use). The neuromate® has been cited in more than 30 published peer-reviewed scientific journal articles.</p>
